Moxibustion for the Treatment of Distal Peripheral Neuropathy in Diabetes Mellitus: A Case Report
Journal of Chinese Medicine
; - (129):30-36, 2022.
Article
in English
| EMBASE | ID: covidwho-1955694
ABSTRACT
Distal sensory peripheral neuropathy (DSPN) in Type 2 diabetes mellitus (T2DM) is a painful chronic condition that affects one’s quality of life. People with DSPN experience pain, numbness, tingling, sensory loss, absent or reduced reflexes, and muscle weakness. Distal sensory peripheral neuropathy in T2DM is typically managed with tricyclic antidepressants, anticonvulsants and opiates. However, side effects can occur with pharmaceuticals, therefore a non-invasive symptom management approach such as moxibustion is worthy of consideration. Unfortunately, moxibustion is often overlooked and not considered a viable method for managing symptoms associated with DSPN. This case report illustrates the success of six moxibustion treatments conducted twice weekly for three weeks. The treatments reduced pain related to DSPN and improved indices of neurosensory testing.
atorvastatin; lisinopril; metformin; SARS-CoV-2 vaccine; adult; article; burn; case report; chronic disease; clinical article; coronavirus disease 2019; disease severity; fenglong acupoint; follow up; gongsun acupoint; heat pain threshold; human; hypesthesia; male; medical history; middle aged; moxibustion; muscle weakness; non insulin dependent diabetes mellitus; pain; paresthesia; peripheral neuropathy; qiuxu acupoint; quality of life; reflex disorder; sanyinjiao acupoint; taichong acupoint; yanglingquan acupoint; yongquan acupoint
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Case report
Language:
English
Journal:
Journal of Chinese Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS